JP Morgan on Wednesday downgraded medical technology company Smith & Nephew (SN.L) to neutral from overweight and lowered the price target to 12.90 pounds sterling from 14.38 pounds.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)